By Research Area
Hot products 
-
Human Anti-SARS-CoV-2 Spike Recombinant Antibody (CR3022) (CBMAB-CR014LY)
-
Rabbit Anti-AP2M1 (Phosphorylated T156) Recombinant Antibody (D4F3) (PTM-CBMAB-0610LY)
-
Mouse Anti-ALX1 Recombinant Antibody (96k) (CBMAB-C0616-FY)
-
Human Anti-SARS-CoV-2 Spike Recombinant Antibody (CBC05) (CBMAB-CR005LY)
-
Mouse Anti-ARHGDIA Recombinant Antibody (CBCNA-009) (CBMAB-R0415-CN)
-
Mouse Anti-AHCYL1 Recombinant Antibody (V2-180270) (CBMAB-A1703-YC)
-
Rabbit Anti-DLK1 Recombinant Antibody (9D8) (CBMAB-D1061-YC)
-
Mouse Anti-COL1A2 Recombinant Antibody (CF108) (V2LY-1206-LY626)
-
Mouse Anti-DHFR Recombinant Antibody (D0821) (CBMAB-D0821-YC)
-
Rat Anti-ABCC11 Recombinant Antibody (V2-179001) (CBMAB-A0236-YC)
-
Mouse Anti-DMPK Recombinant Antibody (CBYCD-324) (CBMAB-D1200-YC)
-
Rabbit Anti-ABL1 (Phosphorylated Y185) Recombinant Antibody (V2-443434) (PTM-CBMAB-0001YC)
-
Mouse Anti-DLL4 Recombinant Antibody (D1090) (CBMAB-D1090-YC)
-
Mouse Anti-CTCF Recombinant Antibody (CBFYC-2371) (CBMAB-C2443-FY)
-
Mouse Anti-ANXA7 Recombinant Antibody (A-1) (CBMAB-A2941-YC)
-
Mouse Anti-dsDNA Recombinant Antibody (22) (CBMAB-AP1954LY)
-
Mouse Anti-8-oxoguanine Recombinant Antibody (V2-7719) (CBMAB-1898CQ)
-
Mouse Anti-BIRC3 Recombinant Antibody (315304) (CBMAB-1214-CN)
-
Mouse Anti-CRYAB Recombinant Antibody (A4345) (CBMAB-A4345-YC)
-
Mouse Anti-ATM Recombinant Antibody (2C1) (CBMAB-A3970-YC)
Breast Cancer Research
Breast cancer is a common malignant tumor that starts in the breast tissue, predominantly impacting women but occasionally occurring in men. As the most common cancer worldwide among women, it accounts for approximately 1/4 of cancer cases in females. Key risk factors include age, genetic mutations (BRCA1/2), lifestyle factors, hormonal effects, and family history. Early detection through mammograms and clinical exams significantly improves outcomes, with 5-year survival rates exceeding 90% for localized cases. Modern treatments range from surgery (lumpectomy/mastectomy) to advanced therapies like targeted drugs (e.g., HER2 inhibitors) and immunotherapy, often combined with chemotherapy, radiation, or hormone therapy based on tumor characteristics. Ongoing research focuses on precision medicine and early biomarkers to enhance prevention and personalized care.
Creative Biolabs is dedicated to developing high-quality, specialized antibodies for breast cancer research. Our antibodies are meticulously optimized to ensure exceptional specificity and sensitivity. Explore our comprehensive antibody portfolio to advance your breast cancer diagnostic and therapeutic development efforts.
Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols
Loading...
Compare
